This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Learn about wealth management strategies for families that can help secure your financial future and provide for your loved ones.
21,982 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Divisadero Street Capital Management upped its stake in Dave (DAVE), fueling questions about a potential buying oppor...
A notable hedge fund adds position in RXO, prompting questions about the stock's future. This guide breaks down what ...
A comprehensive, reader-friendly analysis of CVV's Q4 2025 earnings transcript. Learn how revenue trends, margins, an...
Regulators green-light a new type of BTC trading on Kalshi. Learn how the CFTC's approval of Bitcoin perpetual future...
When rocket stock plummeted today, investors watched a high-growth space company slide on sentiment and macro cues. T...
Investors are eyeing Lilly for its resilient growth, strong pipeline, and shareholder-friendly strategy. This piece b...
UPS has faced a rough stretch, but signs of a turnaround are catching investor attention. This guide explains why Jul...
Two travel giants—Vail Resorts and Viking Holdings—represent different bets on leisure demand. This analysis compares...
A smaller e-commerce stock jumped 25% in 2026, outpacing Amazon’s gains. This guide explains what’s driving the move,...
Investors weigh Pfizer's CFO transition as the broader market climbs. This look at the stock market today, june revea...
SpaceX has fallen roughly a third from its peak, sparking questions about its trajectory. This article outlines four ...